Debt-to-equity in % of Applied Therapeutics, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Applied Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q3 2019 to Q3 2025.
Applied Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 94.8 %, a 61% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	94.8	-148	-61%	30 Sep 2025
Q2 2025	146	-94.2	-39.3%	30 Jun 2025
Q1 2025	120	-628	-84%	31 Mar 2025
Q4 2024	133	+708		31 Dec 2024
Q3 2024	243	+1.36K		30 Sep 2024
Q2 2024	240	-2.85K	-92.2%	30 Jun 2024
Q1 2024	748	+275	+58%	31 Mar 2024
Q4 2023	-575	-767	-399%	31 Dec 2023
Q3 2023	-1.12K	-1.23K	-1148%	30 Sep 2023
Q2 2023	3.09K	+3.03K	+4887%	30 Jun 2023
Q1 2023	474	+439	+1248%	31 Mar 2023
Q4 2022	192	+166	+629%	31 Dec 2022
Q3 2022	107	+83	+346%	30 Sep 2022
Q2 2022	62	+41.2	+198%	30 Jun 2022
Q1 2022	35.1	+16.1	+84.4%	31 Mar 2022
Q4 2021	26.4	+10.5	+65.9%	31 Dec 2021
Q3 2021	24	+7.85	+48.6%	30 Sep 2021
Q2 2021	20.8	+5.71	+37.8%	30 Jun 2021
Q1 2021	19.1	+3.96	+26.2%	31 Mar 2021
Q4 2020	15.9	-31	-66.1%	31 Dec 2020
Q3 2020	16.2	-87.3	-84.4%	30 Sep 2020
Q2 2020	15.1			30 Jun 2020
Q1 2020	15.1			31 Mar 2020
Q4 2019	46.9			31 Dec 2019
Q3 2019	103			30 Sep 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.